NCT07008261 Robot-assisted Cystectomies With Regard to Blood Loss, Pain and Transfusions.
| NCT ID | NCT07008261 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Goethe University |
| Condition | Transfusions |
| Study Type | OBSERVATIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-08-01 |
| Primary Completion | 2027-05-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60 participants in total. It began in 2025-08-01 with a primary completion date of 2027-05-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
What influence does robot-assisted surgical treatment in the sense of a radical cystectomy and possibly bladder reconstruction have on blood loss, pain and transfusion requirements? We intend to conduct a corresponding prospective observational study at a tertiary centre.
Eligibility Criteria
Inclusion Criteria: * planned radical cystectomy Exclusion Criteria: * ASA classification V * Previously known coagulation disorder
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07008261 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Transfusions. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07008261 currently recruiting?
Yes, NCT07008261 is actively recruiting participants. Contact the research team at armin.flinspach@unimedizin-ffm.de for enrollment information.
Where is the NCT07008261 trial being conducted?
This trial is being conducted at Frankfurt am Main, Germany.
Who is sponsoring the NCT07008261 clinical trial?
NCT07008261 is sponsored by Goethe University. The trial plans to enroll 60 participants.